VMD
Viemed Healthcare, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.08
+0.78%Year over year
Reported trailing growth
- Revenue
- +25.2%
- EBITDA
- +18.9%
- EBIT
- +20.2%
- EPS
- +4.9%
- Free cash flow
- +911.4%
- Operating cash flow
- +41.9%
Forward estimates
Based on analyst estimates
- Revenue
- +10.6%
- EBITDA
- +17.5%
- EPS
- +31.7%
Three-year CAGR
- Revenue
- +24.9%
- EBITDA
- +27.6%
- EBIT
- +35.9%
- Net income
- +33.9%
- EPS
- +36.3%
- Free cash flow
- +35.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026